GB0720113D0 - Diagnostic, prognostic and predictive testing for cancer - Google Patents

Diagnostic, prognostic and predictive testing for cancer

Info

Publication number
GB0720113D0
GB0720113D0 GBGB0720113.0A GB0720113A GB0720113D0 GB 0720113 D0 GB0720113 D0 GB 0720113D0 GB 0720113 A GB0720113 A GB 0720113A GB 0720113 D0 GB0720113 D0 GB 0720113D0
Authority
GB
United Kingdom
Prior art keywords
prognostic
diagnostic
cancer
predictive testing
predictive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0720113.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Cancer Diagnostics Ltd
Original Assignee
Cambridge Cancer Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Cancer Diagnostics Ltd filed Critical Cambridge Cancer Diagnostics Ltd
Priority to GBGB0720113.0A priority Critical patent/GB0720113D0/en
Publication of GB0720113D0 publication Critical patent/GB0720113D0/en
Priority to ES08840139T priority patent/ES2395890T3/es
Priority to JP2010529444A priority patent/JP5559056B2/ja
Priority to PT88401393T priority patent/PT2208070E/pt
Priority to EP08840139A priority patent/EP2208070B1/en
Priority to CA2702653A priority patent/CA2702653A1/en
Priority to US12/738,062 priority patent/US8512716B2/en
Priority to CN2008801209233A priority patent/CN101896819A/zh
Priority to DK08840139.3T priority patent/DK2208070T3/da
Priority to AU2008313459A priority patent/AU2008313459B2/en
Priority to PCT/GB2008/003501 priority patent/WO2009050461A1/en
Priority to US13/873,487 priority patent/US20140154680A1/en
Priority to JP2014018906A priority patent/JP5837630B2/ja
Priority to US15/141,908 priority patent/US20180223366A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0720113.0A 2007-10-15 2007-10-15 Diagnostic, prognostic and predictive testing for cancer Ceased GB0720113D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0720113.0A GB0720113D0 (en) 2007-10-15 2007-10-15 Diagnostic, prognostic and predictive testing for cancer
PCT/GB2008/003501 WO2009050461A1 (en) 2007-10-15 2008-10-15 Diagnostic, predictive and prognostic testing for cancer
US12/738,062 US8512716B2 (en) 2007-10-15 2008-10-15 Diagnostic, predictive and prognostic testing for cancer
DK08840139.3T DK2208070T3 (da) 2007-10-15 2008-10-15 Diagnostisk prædiktiv og prognostisk test for cancer
PT88401393T PT2208070E (pt) 2007-10-15 2008-10-15 Testes de diagnóstico, preditivos e de prognóstico para o cancro
EP08840139A EP2208070B1 (en) 2007-10-15 2008-10-15 Diagnostic, predictive and prognostic testing for cancer
CA2702653A CA2702653A1 (en) 2007-10-15 2008-10-15 Diagnostic, predictive and prognostic testing for cancer
ES08840139T ES2395890T3 (es) 2007-10-15 2008-10-15 Ensayo de diagnóstico, predictivo y de prognosis para el cáncer
CN2008801209233A CN101896819A (zh) 2007-10-15 2008-10-15 对癌症的诊断测试、预测测试和预后测试
JP2010529444A JP5559056B2 (ja) 2007-10-15 2008-10-15 ガンの診断、予測、および予後試験
AU2008313459A AU2008313459B2 (en) 2007-10-15 2008-10-15 Diagnostic, predictive and prognostic testing for cancer
US13/873,487 US20140154680A1 (en) 2007-10-15 2013-04-30 Diagnostic, predictive and prognostic testing for cancer
JP2014018906A JP5837630B2 (ja) 2007-10-15 2014-02-03 ガンの診断、予測、および予後試験
US15/141,908 US20180223366A1 (en) 2007-10-15 2016-04-29 Diagnostic, predictive and prognostic testing for cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0720113.0A GB0720113D0 (en) 2007-10-15 2007-10-15 Diagnostic, prognostic and predictive testing for cancer

Publications (1)

Publication Number Publication Date
GB0720113D0 true GB0720113D0 (en) 2007-11-28

Family

ID=38813827

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0720113.0A Ceased GB0720113D0 (en) 2007-10-15 2007-10-15 Diagnostic, prognostic and predictive testing for cancer

Country Status (11)

Country Link
US (3) US8512716B2 (enExample)
EP (1) EP2208070B1 (enExample)
JP (2) JP5559056B2 (enExample)
CN (1) CN101896819A (enExample)
AU (1) AU2008313459B2 (enExample)
CA (1) CA2702653A1 (enExample)
DK (1) DK2208070T3 (enExample)
ES (1) ES2395890T3 (enExample)
GB (1) GB0720113D0 (enExample)
PT (1) PT2208070E (enExample)
WO (1) WO2009050461A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0921873D0 (en) 2009-12-15 2010-01-27 Cytosystems Ltd Assay
SG10201505723UA (en) * 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
AU2013388864B2 (en) * 2013-05-09 2017-06-08 The Procter & Gamble Company Method and system for assessing health condition
CN103592444A (zh) * 2013-11-27 2014-02-19 中国人民解放军沈阳军区总医院 一种检测乳腺癌中cyclin G1蛋白表达并进行预后评估的方法
WO2015187498A1 (en) * 2014-06-01 2015-12-10 Novazoi Theranostics, Inc. Compositions and methods for prognosis and treatment of neoplasm
WO2016131875A1 (en) * 2015-02-17 2016-08-25 Biontech Diagnostics Gmbh Methods and kits for the molecular subtyping of bladder cancer
US11519916B2 (en) 2015-06-08 2022-12-06 Arquer Diagnostics Limited Methods for analysing a urine sample
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
CN105986034A (zh) * 2016-06-15 2016-10-05 南京卡迪睿伯生物技术有限公司 一组胃癌基因的应用
CN108344868B (zh) * 2018-01-23 2020-05-15 郑州大学第一附属医院 人组蛋白H3 Ser10和Ser28在鉴定人早期胚胎的发育分期中的应用
CN108344867B (zh) * 2018-01-23 2020-05-15 郑州大学第一附属医院 人组蛋白H3 Ser10和Ser28在鉴定人卵母细胞成熟分期中的应用
CN111187833A (zh) * 2018-11-14 2020-05-22 上海生物芯片有限公司 Plk1和bub1b基因联合作为肺癌生物标志物的用途
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
CN109988708B (zh) * 2019-02-01 2022-12-09 碳逻辑生物科技(中山)有限公司 一种用于对患有结肠直肠癌的患者进行分型的系统
CN110846413B (zh) * 2019-11-23 2023-05-26 中南大学湘雅三医院 Mafg/mafg-as1/mafg正反馈环作为靶位点检测试剂的应用
CN114019163B (zh) * 2021-11-02 2024-07-23 复旦大学附属中山医院 基于活化b细胞表达的结肠癌预后诊断用标记物及其用途
WO2023150578A2 (en) * 2022-02-01 2023-08-10 4D Path Inc. Systems and methods for image-based disease characterization

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329177A1 (de) * 1993-08-30 1995-03-02 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Klonierung eines neuen Mitgliedes der Familie der Serin-Threonin-Kinasen
DE19915057A1 (de) 1999-04-01 2000-10-19 Forschungszentrum Borstel Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
GB0323225D0 (en) * 2003-10-03 2003-11-05 Ncc Technology Ventures Pte Lt Materials and methods relating to breast cancer classification
DK2163650T3 (en) * 2004-04-09 2015-11-02 Genomic Health Inc Genekspressionsmarkører for prediction of response to chemotherapy
EP1737982A4 (en) * 2004-04-14 2009-09-23 Harvard College NUCLEIC ACID PROGRAMMABLE PROTEIN NETWORKS
US20060063190A1 (en) * 2004-09-22 2006-03-23 Tripath Imaging, Inc Methods and compositions for evaluating breast cancer prognosis
WO2006087557A1 (en) * 2005-02-18 2006-08-24 Astrazeneca Ab METHOD FOR DETERMINING RESPONSIVENESS TO CHKl INHIBITORS
DE602006011959D1 (de) * 2005-12-30 2010-03-11 Ventana Med Syst Inc Na+, k+-atpase-expression bei zervixdysplasie und -krebs
EP1968579A1 (en) * 2005-12-30 2008-09-17 Astex Therapeutics Limited Pharmaceutical compounds

Also Published As

Publication number Publication date
JP2014095726A (ja) 2014-05-22
US20100285474A1 (en) 2010-11-11
CA2702653A1 (en) 2009-04-23
AU2008313459A1 (en) 2009-04-23
US8512716B2 (en) 2013-08-20
DK2208070T3 (da) 2012-12-17
EP2208070A1 (en) 2010-07-21
CN101896819A (zh) 2010-11-24
JP5559056B2 (ja) 2014-07-23
JP2011501809A (ja) 2011-01-13
EP2208070B1 (en) 2012-10-03
WO2009050461A1 (en) 2009-04-23
JP5837630B2 (ja) 2015-12-24
PT2208070E (pt) 2013-01-08
US20140154680A1 (en) 2014-06-05
AU2008313459B2 (en) 2013-01-24
US20180223366A1 (en) 2018-08-09
ES2395890T3 (es) 2013-02-15

Similar Documents

Publication Publication Date Title
GB0720113D0 (en) Diagnostic, prognostic and predictive testing for cancer
EP1922326A4 (en) BIOMARKERS USEFUL FOR DIAGNOSING PROSTATE CANCER AND METHOD OF USE THEREOF
GB2447252B (en) X-ray analysis instrument
GB0719792D0 (en) Cancer biomarkers
GB0701444D0 (en) Detecting analytes
EP2220124A4 (en) DETECTION OF BIOMARKERS
EP2195626A4 (en) HOUSING, WINDOW AND SEAL FOR A MEASURING DEVICE
EP2216655A4 (en) PROBE CARD
ZA200808669B (en) Methods of treating, diagnosing or detecting cancer
EP2515115A4 (en) KIT FOR DIAGNOSIS OF PROSTATE CANCER AND DIAGNOSTIC PROCEDURE
TWI351185B (en) Methods for interference measurement and prediction
GB0719287D0 (en) Prognostic or diagnostic test
GB0801067D0 (en) Data analysis
PL2191006T3 (pl) Sposoby oznaczania aktywności enzymatycznej alfa-L-duronidazy
TWI350376B (en) Test time calculator
GB0700640D0 (en) Detecting analytes
GB0722068D0 (en) Predictive test
AU320560S (en) Diagnostic test system
GB0723338D0 (en) Prognostic assay
GB0618429D0 (en) Cancer test
EP1974213A4 (en) HIGHLY SENSITIVE SECRETAGOGIN ASSAYS AND ITS USE IN DIAGNOSIS AND / OR FORECASTING
AU2008100562A4 (en) Genome-based Diagnosis for Prostate Cancer
ZA201103566B (en) Biomarker for diagnosing cancer
TWI349107B (en) Probe card
GB0807925D0 (en) Data analysis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)